SEHK:6855Biotechs
Assessing Ascentage Pharma Group International’s Valuation After AACR 2026 Preclinical Oncology Selections
Ascentage Pharma Group International (SEHK:6855) has drawn fresh attention after announcing that four abstracts from its preclinical oncology programs will be presented at the AACR Annual Meeting 2026, highlighting several pipeline drug candidates.
See our latest analysis for Ascentage Pharma Group International.
At a share price of HK$47.46, Ascentage Pharma Group International has seen short term share price momentum pick up slightly. The 1 year total shareholder return of 22.64% and 3 year...